Correspondence: Nataporn Chanvarasuth, The National Center for Genetic Engineering and Biotechnology, 73/1 Rama VI Rd., Rajdhevee, Bangkok 10400, Thailand. E-mail: nataporn.cha@biotec.or.th

¹is a policy researcher at the National Center for Genetic Engineering and Biotechnology (BIOTEC) and also in a secretariat to the National Biotechnology Policy Committee. She is one of the team leaders who pushed policy research to establish Biopark and BOI incentive for biotech businesses.

²is the Head of the National Center for Genetic Engineering and Biotechnology's (BIOTEC) Public Relations Section.

Received 22 August 2008; Revised 22 August 2008; Published online 21 October 2008.

Abstract

Thailand's National Biotechnology Policy Framework 2004–2009 acts as a catalyst to enhance industrial productivity and sustainability. Six goals are identified in the national policy framework, of which two are given priority: 'Kitchen of the World' and 'Healthcare Centre of Asia'. The Board of Investment of Thailand (BOI) is creating a positive environment for local and international industries. BOI provides maximum benefit privileges to biotechnology-related investments. Currently, there are 50 new emerging biotechnology companies in Thailand. More than 80 existing businesses have incorporated biotechnology R&D in their work processes. Government agencies and universities provide supporting services to stimulate biotechnology businesses. R&D infrastructures such as Biopark in the expansion phase of Thailand Science Park will be operational in 2010. The National Science and Technology Development Agency, the National Center for Genetic Engineering and Biotechnology, the Thailand Center of Excellence for Life Sciences, and the BOI under the direction of the Ministry of Industry are major agencies committed to strengthening Thailand's competitiveness in biotechnology.